ALPMF News and Press, Astellas Pharma Inc From 09/22/23

2023-09-22 06:49:12 ET More on Merck Seeking Alpha’s Quant Rating on Merck Historical earnings data for Merck Financial information for Merck Merck: Still Fundamentally Undervalued Considering Keytruda's Prospects Merck: A Blue-Chip Dividend St...

2023-09-19 09:29:45 ET More on Astellas, Apellis, etc. Sticking With Apellis: Navigating Syfovre's Safety Measures In A Volatile Market Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Wells Fargo ups Apellis to overweight, stock climbs ...

2023-09-14 04:51:56 ET Astellas Pharma ( OTCPK:ALPMY ) intends to build a new facility, at an approximate cost of €330M in Tralee, Co. Kerry. Ireland. This investment will expand capacity and capabilities for aseptic drug products, reinforce stable production...

2023-09-07 15:39:56 ET Japanese drugmaker Astellas ( OTCPK:ALPMF ) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly instituted policy was unconstitutional. Astellas was one of...

2023-08-23 08:12:30 ET More on Pfizer Pfizer Stock: The Right Time To Buy Now (Technical Analysis) Pfizer: Doubling Down Buying Opportunity Is Here Pfizer's Unexpected Strength: Bullish Case Emerges Amid New Covid-19 Wave Pfizer Inc. ( PFE ) Q2 2023 Ear...

2023-08-16 12:41:31 ET Summary Astellas has closed its Iveric bio, Inc. deal in July and reported JPY 375Bn in quarterly sales in Q1. The company's earnings power and asset factors are bullish, but valuation factors are keeping me neutral. From this, I am closely watching the ...

2023-08-14 07:55:03 ET Summary George Soros's 13F portfolio value decreased slightly from $6.49B to $6.41B, with 172 positions. New stakes include PDC Energy, IVERIC bio, ARK Innovation ETF Calls, Alibaba Group Holding, Five9 Puts, RenaissanceRE Holdings, and MicroStrategy Puts. ...

2023-08-14 07:00:00 ET Summary Biotech stocks faced challenges in the first half of the year, with the Nasdaq Biotechnology Index losing 3%, compared to strong advances in the broader market. The direction of the 10-year bond yield has become a key predictor of biotech industry pe...

2023-08-07 13:54:42 ET More on Apellis Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space Apellis extends selloff as JPMorgan becomes latest to downgrade Apellis off ...

2023-08-07 11:25:39 ET More on Poseida Poseida Therapeutics: Pioneering Cell And Gene Therapies Spark Excitement And Caution Poseida gains on FDA nod to start trials for CAR-T therapy Poseida stock falls ~8% postmarket after founder, executive chairman to step down ...